Table 2.
This table demonstrated comparison between baseline and 6th month parameters
| Parameters | Baseline | 6th Month | P Value |
|---|---|---|---|
| BCVA (LogMAR) | 1.23 ± 0.24 | 0.45 ± 0.28 | < 0.001 |
| Average GCL-IPL Thickness (µm) | 57.98 ± 21.43 | 68.7 ± 13.62 | 0.001 |
| Nasal GCL-IPL Thickness (µm) | 56.94 ± 24.18 | 73.1 ± 15.39 | < 0.001 |
| Temporal GCL-IPL Thickness (µm) | 90.16 ± 32.033 | 93.64 ± 23.38 | 0.619 |
| Superior GCL-IPL Thickness (µm) | 59.76 ± 27.04 | 69.7 ± 15.92 | 0.017 |
| Superotemporal GCL-IPL Thickness (µm) | 60.02 ± 22.33 | 61.02 ± 16.01 | 0.882 |
| Superonasal GCL-IPL Thickness (µm) | 60.64 ± 23.96 | 73.16 ± 17.66 | < 0.001 |
| Inferotemporal GCL-IPL Thickness (µm) | 60.28 ± 21.77 | 65.24 ± 15.88 | 0.162 |
| Inferonasal GCL-IPL Thickness (µm) | 56.64 ± 23.7 | 71.64 ± 17.09 | < 0.001 |
| Inferior GCL-IPL Thickness (µm) | 56.28 ± 25.51 | 72.76 ± 14.15 | < 0.001 |